60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given “Neutral” Rating at HC Wainwright
HC Wainwright reiterated their neutral rating on shares of 60 Degrees Pharmaceuticals (NASDAQ:SXTP – Free Report) in a research note issued to investors on Tuesday morning,Benzinga reports. Separately ...
Invivyd (NASDAQ:IVVD) Earns “Buy” Rating from HC Wainwright
Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright ...
Nuvectis Pharma price target lowered to $11 from $21 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis lowered the firm’s price target on Nuvectis Pharma (NVCT) to $11 from $21 and keeps a Buy rating on ...
Fintel on MSN22h
HC Wainwright & Co. Initiates Coverage of Centrus Energy (LEU) with Buy Recommendation
Fintel reports that on February 25, 2025, HC Wainwright & Co. initiated coverage of Centrus Energy (NYSEAM:LEU) with a Buy ...
H.C. Wainwright Reaffirms Their Hold Rating on 60 Degrees Pharmaceuticals, Inc. (SXTP)
H.C. Wainwright analyst Edward White maintained a Hold rating on 60 Degrees Pharmaceuticals, Inc. (SXTP – Research Report) today. The company’s ...
Analysts eye Bitcoin miners’ AI, chip sales ahead of Q4 earnings
Analysts are watching for revenues from servicing AI models and making microchips ahead of four top Bitcoin mining stocks’ ...
TMCnet1d
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference Date/Time Tuesday, February 25, 2025, at 11:00 a.m. ET. Webcast Link https://journey.ct.events/view/acb6057e-9d9b-427e-b490-eaf85a5c2910 ...
Investing14d
H.C. Wainwright maintains Buy on OKYO Pharma with $7 target
On Tuesday, H.C. Wainwright reiterated its Buy rating on OKYO Pharma Ltd. (NASDAQ: OKYO) with a price target of $7.00, representing significant upside potential from the current trading price of $1.10 ...